Arabic Arabic English English French French German German
dark

Stallergenes Greer and Alyatec Announce Research Collaboration to Advance Precision Medicine in Allergen Immunotherapy

Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy, and Alyatec, a contract research organisation based in Strasbourg University Hospital, announced that they have entered into a collaboration to advance precision medicine in AIT. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Muna Therapeutics Raises $73 Million to Advance Neurodegenerative Disease Focus

Next Post

Hansa Biopharma announces long term follow-up data demonstrating 3-year graft survival of 84% after imlifidase treatment and transplantation

Related Posts
Total
0
Share